Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Phenomix Corp.

Latest From Phenomix Corp.

Appointments: Synthorx, BTG, Pertinax, Realm, Breath, Aerie, iOnctura, Inflazome and NBE

The week's round-up includes a new CEO at Synthorx Inc., new sales executives at Aerie Pharmaceuticals and board appointments at BTG, Pertinax Pharma, Realm Therapeutics, Breath Therapeutics, iOnctura, NBE Therapeutics and Inflazome.

Appointments BioPharmaceutical

Looking For The New Lantus: Next-Gen Diabetes Hopefuls Defy Risks

The diabetes market presents competitive, commercial, and regulatory challenges, but its size and breadth spur emerging biotechs to develop an ever-wider range of treatments and technologies.

BioPharmaceutical Clinical Trials

Cleave Gains Further Validation From Investors With Addition Of $10M To Its Series A

The California biotech proves that an early-stage company can be just as attractive to investors as a proof-of-concept biotech if the science is strong.

BioPharmaceutical North America

EnVivo names Christopher Burnley CBO

EnVivo Pharmaceuticals, a company dedicated to developing novel CNS therapies, has appointed Christopher Burnley chief business officer. Mr Burnley was previously a founder and CEO of VetRx, a biotechnology start-up to develop human biologics for use in companion animals. Before forming VetRx, he served as executive vice-president and chief operating officer of Phenomix Corporation.

See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
      • Genomics-Proteomics
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Phenomix Corp.
  • Senior Management
  • Laura K Shawver, PhD, CEO
    Hans-Peter Guler, MD, CMO
    Brian Baker, VP, Fin.
  • Contact Info
  • Phenomix Corp.
    Phone: (858) 731-5200
    5930 Cornerstone Ct. West, Ste. 230
    San Diego, CA 92121